Disease Landscape and Forecast Insights

Report September 1, 2022

Non-Hodgkin’s Lymphoma – Epidemiology – Americas

Clarivate Epidemiology’s coverage of non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) comprises epidemiological estimates of key patient populations in 45 countries worldwide…

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma – Epidemiology – Emerging Markets

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma – Epidemiology – Mature Markets

north_east

Report August 10, 2022

Cholangiocarcinoma – Epidemiology – Extrapolated worldwide coverage

Clarivate’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key non-small-cell lung cancer patient populations covering 171 countries…

north_east

Report July 22, 2022

Non-Small-Cell Lung Cancer | Current Treatment: Physician Insights | US | 2022

The current treatment armamentarium for non-small-cell lung cancer (NSCLC) is dominated by biomarker-driven therapies and immune checkpoint inhibitors. Therapeutic options in this indication have…

north_east

Report July 8, 2022

Non-Small-Cell Lung Cancer | Treatment Sequencing | US | 2022

KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand whom to…

north_east

Report May 18, 2022

Non-Small-Cell Lung Cancer | Unmet Need | US/EU5 | 2022

Metastatic non-small-cell lung cancer (NSCLC) is a highly segmented indication defined by tumor histology and mutational status. Metastatic nonsquamous NSCLC patients are routinely tested for the…

north_east

Report May 18, 2022

Non-Small-Cell Lung Cancer – Unmet Need – Unmet Need – Metastatic Nonsquamous Non-Small-Cell Lung Cancer Without Driver Mutations (US/EU)

Metastatic non-small-cell lung cancer (NSCLC) is a highly segmented indication defined by tumor histology and mutational status. Metastatic nonsquamous NSCLC patients are routinely tested for the…

north_east

Report May 6, 2022

Squamous Cell Carcinoma of the Head and Neck – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of SCCHN comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed events of SCCHN for each country, as…

north_east

Report April 19, 2022

Non-Small-Cell Lung Cancer – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of non-small-cell lung cancer (NSCLC) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report April 19, 2022

Non-Small-Cell Lung Cancer – Epidemiology – Asia-Pacific

Clarivate Epidemiology’s coverage of non-small-cell lung cancer (NSCLC) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report April 19, 2022

Non-Small-Cell Lung Cancer – Epidemiology – Americas

Clarivate Epidemiology’s coverage of non-small-cell lung cancer (NSCLC) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Product logins

Disease Landscape and Forecast Insights

Non-Hodgkin’s Lymphoma – Epidemiology – Americas

Non-Hodgkin’s Lymphoma – Epidemiology – Emerging Markets

Non-Hodgkin’s Lymphoma – Epidemiology – Mature Markets

Cholangiocarcinoma – Epidemiology – Extrapolated worldwide coverage

Non-Small-Cell Lung Cancer | Current Treatment: Physician Insights | US | 2022

Non-Small-Cell Lung Cancer | Treatment Sequencing | US | 2022

Non-Small-Cell Lung Cancer | Unmet Need | US/EU5 | 2022

Non-Small-Cell Lung Cancer – Unmet Need – Unmet Need – Metastatic Nonsquamous Non-Small-Cell Lung Cancer Without Driver Mutations (US/EU)

Squamous Cell Carcinoma of the Head and Neck – Epidemiology – Epidemiology Dashboard

Non-Small-Cell Lung Cancer – Epidemiology – Middle East & Africa

Non-Small-Cell Lung Cancer – Epidemiology – Asia-Pacific

Non-Small-Cell Lung Cancer – Epidemiology – Americas

Follow us

Contact us